chr2-26458218-C-T
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_194323.3(OTOF):c.3515G>A(p.Arg1172Gln) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000684 in 1,578,266 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_194323.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOF | NM_194248.3 | c.*20G>A | splice_region_variant | 47/47 | ENST00000272371.7 | NP_919224.1 | ||
OTOF | NM_194323.3 | c.3515G>A | p.Arg1172Gln | missense_variant, splice_region_variant | 29/29 | ENST00000339598.8 | NP_919304.1 | |
OTOF | NM_194248.3 | c.*20G>A | 3_prime_UTR_variant | 47/47 | ENST00000272371.7 | NP_919224.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOF | ENST00000272371.7 | c.*20G>A | splice_region_variant | 47/47 | 1 | NM_194248.3 | ENSP00000272371.2 | |||
OTOF | ENST00000339598.8 | c.3515G>A | p.Arg1172Gln | missense_variant, splice_region_variant | 29/29 | 1 | NM_194323.3 | ENSP00000344521.3 | ||
OTOF | ENST00000272371 | c.*20G>A | 3_prime_UTR_variant | 47/47 | 1 | NM_194248.3 | ENSP00000272371.2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152070Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000434 AC: 8AN: 184120Hom.: 0 AF XY: 0.0000506 AC XY: 5AN XY: 98812
GnomAD4 exome AF: 0.0000729 AC: 104AN: 1426078Hom.: 1 Cov.: 31 AF XY: 0.0000680 AC XY: 48AN XY: 706214
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152188Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74400
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 04, 2023 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function and a deleterious effect on splicing; This variant is associated with the following publications: (PMID: 35248088, 26346818, 31095577, 26632695, 24053799, 30482216, 24814232, 23562982, 27621663, 16097006, 22906306, 22575033, 14635104, 12525542, 34426522, 34424407) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 05, 2023 | The OTOF gene has multiple clinically relevant transcripts. This variant occurs in alternate transcript NM_194323.2, and corresponds to NM_194248.2:c.*20G>A in the primary transcript. This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1172 of the OTOF protein (p.Arg1172Gln). This variant is present in population databases (rs201326023, gnomAD 0.02%). This missense change has been observed in individual(s) with auditory neuropathy spectrum disorder (PMID: 26632695). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as p.R1939Q. ClinVar contains an entry for this variant (Variation ID: 548986). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic. - |
Auditory neuropathy spectrum disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Department of Otolaryngology, Head and Neck Surgery, Beijing Friendship Hospital, Capital Medical University | Oct 20, 2020 | - - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 06, 2024 | The c.*20G>A alteration is located in the 3' untranslated region (3' UTR) of the OTOF gene. This alteration consists of a G to A substitution 20 nucleotides after the last coding exon of the OTOF gene. Report as NM_001287489 c.5816G>A (p.R1939Q) - requires manual report edits Based on data from gnomAD, the A allele has an overall frequency of 0.004% (9/215492) total alleles studied. The highest observed frequency was 0.027% (4/14656) of East Asian alleles. This variant has been identified in the homozygous state and/or in conjunction with other OTOF variants in individuals with hearing loss (Matsunaga, 2012; Chang, 2015; Lee, 2021). Based on the available evidence, this alteration is classified as pathogenic. - |
OTOF-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 04, 2023 | The OTOF c.5816G>A variant is predicted to result in the amino acid substitution p.Arg1939Gln. This variant was reported in the homozygous and compound heterozygous states in multiple individuals with auditory neuropathy or nonsyndromic hearing loss (described as c.6141G>A, Varga. 2003. PubMed ID: 12525542; Chang. 2015. PubMed ID: 26632695; Matsunaga. 2012. PubMed ID: 22575033; Table S1, Thorpe. 2021. PubMed ID: 34424407; Mutai. 2022. PubMed ID: 35248088). This variant is reported in 0.027% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-26681086-C-T). This variant is interpreted as pathogenic. - |
Autosomal recessive nonsyndromic hearing loss 9 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Division of Hearing and Balance Research, National Hospital Organization Tokyo Medical Center | Feb 20, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at